View by type:
Articles (4204)
Mpox continues to spread in countries with little access to vaccines
Mpox is continuing to circulate in Africa, Asia and Latin America, where access to vaccines is patchy or non-existent.
Where delivering health care means facing down armed bandits
In northwest Nigeria, some health workers are facing down danger to care for embattled communities.
What misusing antibiotics is really costing us
As antimicrobial resistance rises and some infections become incredibly hard, sometimes impossible, to cure, here’s how the costs of inaction are stacking up.
Retired nurses turn reinforcements at short-staffed Lagos health facilities
As Nigeria grapples with a brain drain of skilled health workers, retired nurses are being redeployed to the healthcare frontlines in the country’s commercial capital.
“Promising” trial results suggest chikungunya vaccine could be within reach
A phase 3 trial suggests the VLA1553 chikungunya vaccine candidate is safe, well tolerated and provokes strong antibody responses in 99% of recipients.
The Global Vaccine Impact Conference closed today, as the Vaccine Alliance marked more than 1 billion children vaccinated through its programmes.
Faster with wings: Ghana’s immunisation rates soar in Zipline-served districts
Drone delivery of vaccines has helped immunisation programmes in remote parts of Ghana’s Western North region bounce back faster than average from the pandemic’s impact, new research says. VaccinesWork visited the Zipline regional hub to find out…
Global Vaccine Impact Conference: Day One & Two Highlights
The Global Vaccine Impact Conference is bringing together some of the biggest names in global immunisation in Madrid from the 13-15 June. Here are some of the key quotes from the first two days.
Vaccine Alliance reaches more than one billion children
Gavi, the Vaccine Alliance, has now facilitated the immunisation of more than one billion children with childhood vaccines.
Global leaders and immunisation experts are coming together to assess the progress of the Vaccine Alliance and discuss the challenges it faces in the future.
11 key stats from Gavi’s Mid-Term Review
In 2019 Gavi set out a list of targets to boost immunisation across the globe for the 2021–25 period. Halfway through the period, how is it measuring up?
“Honestly, it was very exciting”: Gavi’s longest-serving staffer looks back to the very beginning
With Gavi shortly to release its Mid Term Review report, VaccinesWork is in a mood for reflection. We invited Corina Roberts, who joined Gavi in 2000, to sit down with us and take a look back across the decades.